Vitamin D benefits patients with advanced skin cancer (melanoma) who are receiving immunotherapy medications (immune checkpoint inhibitors).
Patients with advanced skin cancer (melanoma) should maintain normal levels of vitamin D when receiving immunotherapy drugs called immune checkpoint inhibitors, suggests a new study. // The findings of the study are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Role of Vitamin D in Cancer Treatment
Vitamin D has many effects on the body, including regulation of the immune system. To see whether levels of vitamin D might impact the effectiveness of immune checkpoint inhibitors, investigators analyzed the blood of 200 patients with advanced melanoma both before and every 12 weeks during immunotherapy treatment.‘Maintaining normal vitamin D levels may benefit advanced skin cancer patients who are receiving immunotherapy medications known as immune checkpoint inhibitors.’
Read More..
A favorable response rate to immune checkpoint inhibitors was observed in 56.0% of patients in the group with normal baseline vitamin D levels or normal levels obtained with vitamin D supplementation, compared with 36.2% in the group with low vitamin D levels without supplementation. Progression‐free survival—the time from treatment initiation until cancer progression—in these groups was 11.25 and 5.75 months, respectively. Read More..
“Of course, vitamin D is not itself an anti-cancer drug, but its normal serum level is needed for the proper functioning of the immune system, including the response that anti-cancer drugs like immune checkpoint inhibitors affect,” said lead author Łukasz Galus, MD, of Poznan University of Medical Sciences, in Poland.
“In our opinion, after appropriately randomized confirmation of our results, the assessment of vitamin D levels and its supplementation could be considered in the management of melanoma.”
Source-Eurekalert